Rosalind M Delisser, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 2 carriers
- Office
- 1
- Since medical school
- 24 years
- Graduated 2002
Offices
1 location · University of California San Francisco · 1,780 clinicians in this group
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Rosalind M Delisser’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$19,683
Medicare paid this office $19,683 for 22 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 18 | $7,425 | $69 |
| Psychotherapy with evaluation and management visit, 1 hour | 14 | $3,387 | $74 |
| Long return visit (40+ min) | 13 | $2,616 | $109 |
| Psychotherapy with evaluation and management visit, 30 minutes | 15 | $2,513 | $43 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $1,922 | $58 |
Who their Medicare patients are
22 Original Medicare patients in 2024. Average age 59 · Health risk score 1.96. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: Depression 73% · High blood pressure 64%.
The office billed $152,494, Medicare allowed $26,203 and paid $19,683; for 307 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 22 | 307 | 59 | 1.96 | $152,494 | $19,683 |
| 2023 | 19 | 207 | 55 | 2.15 | $98,715 | $13,879 |
| 2022 | 16 | 125 | 55 | 1.53 | $57,329 | $7,128 |
| 2021 | 18 | 136 | 57 | 1.99 | $62,408 | $8,495 |
| 2020 | 25 | 133 | 57 | 2.01 | $50,268 | $6,453 |
| 2019 | 16 | 62 | 58 | 2.36 | $34,306 | $3,794 |
| 2018 | 11 | 42 | 56 | 1.53 | $23,759 | $2,412 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 16 | $4,525 | $72 |
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $1,799 | $43 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $1,460 | $58 |
2022: 2 services
| Return visit (30+ min) | 14 | $2,879 | $65 |
| Psychotherapy with evaluation and management visit, 30 minutes | 14 | $1,583 | $39 |
2021: 2 services
| Return visit (30+ min) | 13 | $3,593 | $76 |
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $1,344 | $46 |
2020: 1 service
| Return visit (30+ min) | 16 | $1,989 | $57 |
2019: 1 service
| Return visit (30+ min) | 11 | $1,368 | $57 |
Drugs they prescribed that Part D paid
$54,902
Pharmacies billed $54,902 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
363 generic and 38 brand-name prescriptions · $54,902 in drug cost · 29 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Aripiprazole | 18 | $8,315 | $462 |
| Buprenorphine-Naloxone | 32 | $4,607 | $144 |
| Bupropion Xl | 54 | $2,711 | $50 |
| Lurasidone | 17 | $1,258 | $74 |
| Gabapentin | 48 | $686 | $14 |
See all 10 drugs
| Aripiprazole | 18 | $8,315 | $462 |
| Buprenorphine-Naloxone | 32 | $4,607 | $144 |
| Bupropion Xl | 54 | $2,711 | $50 |
| Lurasidone | 17 | $1,258 | $74 |
| Gabapentin | 48 | $686 | $14 |
| Quetiapine | 25 | $455 | $18 |
| Trazodone | 16 | $131 | $8 |
| Lamotrigine | 14 | $65 | $5 |
| Risperidone | 18 | $54 | $3 |
| Clonazepam | 19 | $45 | $2 |
Year by year
| 2024 | 401 | 23 | None | 9% | $54,902 |
| 2023 | 398 | 22 | 3% (11) | 6% | $29,529 |
| 2022 | 479 | 19 | None | 6% | $77,465 |
| 2021 | 474 | 22 | None | 12% | $111,523 |
| 2020 | 345 | 20 | None | 17% | $54,919 |
| 2019 | 237 | 19 | None | 13% | $19,358 |
| 2018 | 164 | None | 0% (0) | None | $12,920 |
| 2017 | 41 | None | 0% (0) | 0% | $2,218 |
| 2014 | 26 | None | 0% (0) | 0% | $214 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Buprenorphine-Naloxone | 17 | $4,932 | $290 |
| Vyvanse | 11 | $4,124 | $375 |
| Bupropion Xl | 85 | $1,971 | $23 |
| Aripiprazole | 13 | $1,386 | $107 |
| Olanzapine | 15 | $849 | $57 |
| Mirtazapine | 42 | $736 | $18 |
| Lamotrigine | 26 | $719 | $28 |
| Guanfacine | 16 | $647 | $40 |
| Amitriptyline | 13 | $379 | $29 |
| Trazodone | 24 | $299 | $12 |
| Buspirone | 12 | $284 | $24 |
| Clonazepam | 18 | $241 | $13 |
| Gabapentin | 14 | $232 | $17 |
| Sertraline | 12 | $105 | $9 |
2022: 13 drugs
| Buprenorphine-Naloxone | 20 | $14,220 | $711 |
| Vyvanse | 11 | $4,171 | $379 |
| Aripiprazole | 35 | $2,975 | $85 |
| Bupropion Xl | 82 | $1,544 | $19 |
| Mirtazapine | 51 | $763 | $15 |
| Gabapentin | 22 | $533 | $24 |
| Venlafaxine Hcl Er | 33 | $516 | $16 |
| Olanzapine | 20 | $284 | $14 |
| Lamotrigine | 15 | $242 | $16 |
| Amitriptyline | 13 | $197 | $15 |
| Trazodone | 22 | $169 | $8 |
| Sertraline | 42 | $149 | $4 |
| Clonazepam | 23 | $83 | $4 |
2021: 14 drugs
| Abilify Maintena | 13 | $32,675 | $2,513 |
| Buprenorphine-Naloxone | 22 | $8,558 | $389 |
| Vyvanse | 13 | $4,602 | $354 |
| Bupropion Xl | 54 | $2,349 | $43 |
| Aripiprazole | 37 | $1,751 | $47 |
| Mirtazapine | 37 | $925 | $25 |
| Divalproex | 11 | $528 | $48 |
| Guanfacine | 24 | $426 | $18 |
| Venlafaxine Hcl Er | 33 | $407 | $12 |
| Amitriptyline | 15 | $338 | $23 |
| Olanzapine | 25 | $211 | $8 |
| Buspirone | 21 | $162 | $8 |
| Sertraline | 42 | $154 | $4 |
| Clonazepam | 21 | $73 | $3 |
2020: 14 drugs
| Latuda | 13 | $15,912 | $1,224 |
| Suboxone | 21 | $11,062 | $527 |
| Buprenorphine-Naloxone | 18 | $4,007 | $223 |
| Aripiprazole | 22 | $2,095 | $95 |
| Bupropion Xl | 26 | $1,258 | $48 |
| Mirtazapine | 33 | $714 | $22 |
| Trazodone | 12 | $602 | $50 |
| Guanfacine | 18 | $391 | $22 |
| Venlafaxine Hcl Er | 30 | $362 | $12 |
| Buspirone | 19 | $108 | $6 |
| Escitalopram | 14 | $86 | $6 |
| Diazepam | 12 | $81 | $7 |
| Clonazepam | 13 | $62 | $5 |
| Sertraline | 19 | $46 | $2 |
2019: 8 drugs
| Suboxone | 24 | $12,112 | $505 |
| Aripiprazole | 17 | $1,687 | $99 |
| Bupropion Xl | 23 | $797 | $35 |
| Mirtazapine | 25 | $571 | $23 |
| Venlafaxine Hcl Er | 18 | $333 | $19 |
| Olanzapine | 13 | $257 | $20 |
| Gabapentin | 18 | $164 | $9 |
| Clonazepam | 11 | $38 | $3 |
2018: 8 drugs
| Bupropion Xl | 16 | $752 | $47 |
| Mirtazapine | 19 | $213 | $11 |
| Quetiapine | 11 | $161 | $15 |
| Venlafaxine Hcl Er | 14 | $123 | $9 |
| Gabapentin | 18 | $109 | $6 |
| Fluoxetine | 15 | $69 | $5 |
| Clonazepam | 14 | $20 | $1 |
| Sertraline | 11 | $18 | $2 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1538248927
- Licence
- CA NP13984
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 1622 Eligio Ln, Davis, CA, 95618
- NPI first listed
- 2006-11-04
- NPI last updated
- 2025-08-13
- NPI record certified
- 2025-08-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 717 7th St, Davis, CA, 95616